SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-014751
Filing Date
2021-01-22
Accepted
2021-01-22 16:16:02
Documents
12
Period of Report
2021-01-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d115835d8k.htm   iXBRL 8-K 26027
  Complete submission text file 0001193125-21-014751.txt   153173

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grts-20210115.xsd EX-101.SCH 3096
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20210115_lab.xml EX-101.LAB 18887
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20210115_pre.xml EX-101.PRE 11877
5 EXTRACTED XBRL INSTANCE DOCUMENT d115835d8k_htm.xml XML 3467
Mailing Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 21546010
SIC: 2836 Biological Products, (No Diagnostic Substances)